How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
61
THC Quote, Financials, Valuation and Earnings
Last price:
$134.71
Seasonality move
:
5.42%
Day range:
$131.39 - $135.81
52-week range:
$90.03 - $171.20
Dividend yield:
0%
P/E ratio:
4.13x
P/S ratio:
0.63x
P/B ratio:
3.04x
Volume:
864.4K
Avg. volume:
1.8M
1-year change:
26.67%
Market cap:
$12.7B
Revenue:
$20.7B
EPS (TTM):
$32.23
Analysts' Opinion
-
Consensus RatingTenet Healthcare has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $171.37, Tenet Healthcare has an estimated upside of 28.72% from its current price of $133.14.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $134.00 representing 100% downside risk from its current price of $133.14.
Fair Value
-
According to the consensus of 16 analysts, Tenet Healthcare has 28.72% upside to fair value with a price target of $171.37 per share.
THC vs. S&P 500
-
Over the past 5 trading days, Tenet Healthcare has overperformed the S&P 500 by 9.75% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Tenet Healthcare does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tenet Healthcare revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Tenet Healthcare reported revenues of $5.1B.
Earnings Growth
-
Tenet Healthcare has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Tenet Healthcare reported earnings per share of $3.32.
Enterprise value:
27.2B
EV / Invested capital:
--
Price / LTM sales:
0.63x
EV / EBIT:
4.48x
EV / Revenue:
1.32x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
24.37x
Price / Operating cash flow:
11.68x
Enterprise value / EBITDA:
3.95x
Gross Profit (TTM):
$17B
Return On Assets:
11.05%
Net Income Margin (TTM):
15.49%
Return On Equity:
42.47%
Return On Invested Capital:
15.32%
Operating Margin:
15.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $19.2B | $20.5B | $20.7B | $5.4B | $5.1B | |
| Gross Profit | $15.9B | $17B | $17B | $4.4B | $4.1B | |
| Operating Income | $2.4B | $2.4B | $2.9B | $723M | $777M | |
| EBITDA | $3.1B | $3.4B | $6.9B | $962M | $1.1B | |
| Diluted EPS | $3.71 | $5.71 | $32.23 | $2.30 | $3.32 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.1B | $7.1B | $6B | $7.2B | $7.7B | |
| Total Assets | $27.1B | $27.6B | $27.2B | $28.3B | $28.9B | |
| Current Liabilities | $4.8B | $5.1B | $4.5B | $4.8B | $4.3B | |
| Total Liabilities | $24.2B | $23.3B | $22.5B | $22.8B | $20.4B | |
| Total Equity | $2.9B | $4.3B | $4.6B | $5.5B | $8.5B | |
| Total Debt | $15.7B | $15.6B | $15.1B | $15B | $13.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.1B | $2.4B | $2B | $824M | -$331M | |
| Cash From Investing | -$808M | -$969M | $3.4B | -$333M | -$372M | |
| Cash From Financing | -$1.8B | -$1B | -$3.7B | -$317M | -$372M | |
| Free Cash Flow | $321M | $1.6B | $1.1B | $616M | -$661M | |
THC
Sector
Market Cap
$12.7B
$36.4M
Price % of 52-Week High
77.77%
44.07%
Dividend Yield
0%
0%
Shareholder Yield
8.71%
-1.03%
1-Year Price Total Return
26.67%
-41.85%
Beta (5-Year)
2.064
0.775
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$129.77
200-day SMA
Sell
Level
$143.62
Bollinger Bands (100)
Sell
Level
125.56 - 149.4
Chaikin Money Flow
Sell
Level
-257.7M
20-day SMA
Buy
Level
$126.70
Relative Strength Index (RSI14)
Buy
Level
55.72
ADX Line
Buy
Level
21.73
Williams %R
Neutral
Level
-22.9015
50-day SMA
Buy
Level
$132.39
MACD (12, 26)
Buy
Level
0.10
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Sell
Level
-261.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0455)
Sell
CA Score
(Annual)
Level (-1.0574)
Sell
Beneish M-Score
(Annual)
Level (-2.2141)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.8276)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Stock Forecast FAQ
In the current month, THC has received 12 Buy ratings 4 Hold ratings, and 0 Sell ratings. The THC average analyst price target in the past 3 months is $171.37.
-
Where Will Tenet Healthcare Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tenet Healthcare share price will rise to $171.37 per share over the next 12 months.
-
What Do Analysts Say About Tenet Healthcare?
Analysts are divided on their view about Tenet Healthcare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tenet Healthcare is a Sell and believe this share price will drop from its current level to $134.00.
-
What Is Tenet Healthcare's Price Target?
The price target for Tenet Healthcare over the next 1-year time period is forecast to be $171.37 according to 16 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is THC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tenet Healthcare is a Buy. 12 of 16 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of THC?
You can purchase shares of Tenet Healthcare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tenet Healthcare shares.
-
What Is The Tenet Healthcare Share Price Today?
Tenet Healthcare was last trading at $134.71 per share. This represents the most recent stock quote for Tenet Healthcare. Yesterday, Tenet Healthcare closed at $133.14 per share.
-
How To Buy Tenet Healthcare Stock Online?
In order to purchase Tenet Healthcare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 31
Ajinomoto [AJINY] is down 1.83% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
69
AGX alert for Mar 31
Argan [AGX] is down 4.98% over the past day.
